pharmaceutical formulation, device adapted for intranasal delivery of a pharmaceutical formulation, and use of a pharmaceutical formulation

摘要

1/1 summary “pharmaceutical formulation, device adapted for intranasal distribution of a pharmaceutical formulation, treatment method for allergic rhinitis, use of a pharmaceutical formulation, and method Treatment of Inflammatory and / or Allergic Condition The present invention relates to pharmaceutical formulations comprising an anti-inflammatory glucocorticoid compound of the androstane and levocabastine series, and an antagonist h / antiallergic. The present invention also relates to their therapeutic uses, particularly for the treatment of inflammatory and allergic conditions, specifically rhinitis.